{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:49:44Z","timestamp":1786736984216,"version":"build-2736575974"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Pharm Bioall Sci"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/jpbs.jpbs_226_19","type":"journal-article","created":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T09:36:21Z","timestamp":1586943381000},"page":"155","source":"Crossref","is-referenced-by-count":6,"title":["Adverse drug reaction profile in Amravati region of India: A pharmacovigilance study"],"prefix":"10.4103","volume":"12","author":[{"given":"ShilpaS","family":"Ingle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KishorA","family":"Bansod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MohammedShakeel Mohammed","family":"Bashir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0975-7406.282490-1","unstructured":"World Health Organization. The importance of pharmacovigilance. Safety monitoring of medicinal products. 2002. Available from: http:\/\/apps.who.int\/medicinedocs\/pdf\/s4893e\/s4893e.pdf.[Last accessed on 2019 September 23]."},{"key":"key-10.4103\/0975-7406.282490-2","first-page":"46","article-title":"A pharmacovigilance study in the department of medicine of a university teaching hospital","author":"Himanshu","year":"2007","journal-title":"Pharm Pract (Granada)"},{"key":"key-10.4103\/0975-7406.282490-3","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/cpt.677","article-title":"Adverse drug reactions in children: the double-edged sword of therapeutics","author":"Elzagallaai","year":"2017","journal-title":"Clin Pharmacol Ther"},{"key":"key-10.4103\/0975-7406.282490-4","first-page":"5","article-title":"Adverse drug reaction monitoring: support for pharmacovigilance at a tertiary care hospital in Northern Brazil","author":"M\u00e1rcia","year":"2013","journal-title":"BMC Pharmacol Toxicol"},{"key":"key-10.4103\/0975-7406.282490-5","doi-asserted-by":"crossref","first-page":"e1001407","DOI":"10.1371\/journal.pmed.1001407","article-title":"Number of patients studied prior to approval of new medicines: A database analysis","author":"Duijnhoven","year":"2013","journal-title":"PLoS Med"},{"key":"key-10.4103\/0975-7406.282490-6","doi-asserted-by":"crossref","first-page":"E55","DOI":"10.3390\/healthcare7020055","article-title":"Studying the evolving knowledge of adverse drug reactions in order to facilitate the rational use of medicines in paediatric patients","author":"Star","year":"2019","journal-title":"Healthcare (Basel)"},{"key":"key-10.4103\/0975-7406.282490-7","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s40264-015-0387-4","article-title":"Adverse drug reaction reporting in Africa and a comparison of individual case safety report characteristics between Africa and the rest of the world: Analyses of spontaneous reports in VigiBase\u00ae","author":"Ampadu","year":"2016","journal-title":"Drug Saf"},{"key":"key-10.4103\/0975-7406.282490-8","doi-asserted-by":"crossref","first-page":"374","DOI":"10.4103\/ijp.IJP_733_16","article-title":"Comparison of online reporting systems and their compatibility check with respective adverse drug reaction reporting forms","author":"Maharshi","year":"2017","journal-title":"Indian J Pharmacol","ISSN":"https:\/\/id.crossref.org\/issn\/0253-7613","issn-type":"print"},{"key":"key-10.4103\/0975-7406.282490-9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/bcp.12944","article-title":"Adverse drug event reporting systems: A systematic review","author":"Bailey","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"key-10.4103\/0975-7406.282490-10","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1136\/bmj.39323.586123.BE","article-title":"Pharmacovigilance in developing countries","author":"Pirmohamed","year":"2007","journal-title":"BMJ"},{"key":"key-10.4103\/0975-7406.282490-11","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1007\/s11096-017-0570-z","article-title":"Pharmacovigilance in developing countries (part I): Importance and challenges","author":"Elshafie","year":"2018","journal-title":"Int J Clin Pharm"},{"key":"key-10.4103\/0975-7406.282490-12","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/tmi.12481","article-title":"Adverse drug reaction reports for cardiometabolic drugs from sub-Saharan Africa: A study in VigiBase","author":"Berhe","year":"2015","journal-title":"Trop Med Int Health"},{"key":"key-10.4103\/0975-7406.282490-13","first-page":"1","article-title":"Development of a pharmacovigilance system in a resource-limited country: The experience of the Democratic Republic of Congo","author":"Nzolo","year":"2019","journal-title":"Ther Adv Drug Saf"},{"key":"key-10.4103\/0975-7406.282490-14","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s40264-019-00807-4","article-title":"Pharmacovigilance systems in Arab countries: Overview of 22 Arab countries","author":"Alshammari","year":"2019","journal-title":"Drug Saf"},{"key":"key-10.4103\/0975-7406.282490-15","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40545-019-0178-x","article-title":"Current status and future prospects of pharmacovigilance in Pakistan","author":"Hussain","year":"2019","journal-title":"J Pharm Policy Pract"},{"key":"key-10.4103\/0975-7406.282490-16","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s40264-018-0730-7","article-title":"Pharmacovigilance in India: present scenario and future challenges","author":"Kalaiselvan","year":"2019","journal-title":"Drug Saf"},{"key":"key-10.4103\/0975-7406.282490-17","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1365-2125.1996.tb00004.x","article-title":"Adverse drug reactions in a hospital general medicine unit meriting notification to the Committee on Safety of Medicines","author":"Smith","year":"1996","journal-title":"Br J Clin Pharmacol"},{"key":"key-10.4103\/0975-7406.282490-18","first-page":"95","article-title":"A pharmacovigilance study in medicine department of tertiary care hospital in Chhattisgarh (Jagdalpur), India","author":"Singh","year":"2010","journal-title":"J Young Pharm"},{"key":"key-10.4103\/0975-7406.282490-19","doi-asserted-by":"crossref","first-page":"e0132916","DOI":"10.1371\/journal.pone.0132916","article-title":"Patterns of adverse drug reactions in different age groups: analysis of spontaneous reports by community pharmacists","author":"Yu","year":"2015","journal-title":"PLoS One"},{"key":"key-10.4103\/0975-7406.282490-20","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1177\/009127009803801103","article-title":"Gender differences in adverse drug reactions","author":"Tran","year":"1998","journal-title":"J Clin Pharmacol"},{"key":"key-10.4103\/0975-7406.282490-21","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2165\/00003495-199550020-00003","article-title":"Gender effects in pharmacokinetics and pharmacodynamics","author":"Harris","year":"1995","journal-title":"Drugs"},{"key":"key-10.4103\/0975-7406.282490-22","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1136\/bmj.316.7143.1511","article-title":"Adverse reactions to drugs","author":"Vervloet","year":"1998","journal-title":"BMJ"},{"key":"key-10.4103\/0975-7406.282490-23","first-page":"221","article-title":"Age- and gender-related differences in drug utilisation and adverse drug reaction patterns among patients in a coronary care unit","author":"Kunnoor","year":"2004","journal-title":"Singapore Med J","ISSN":"https:\/\/id.crossref.org\/issn\/0037-5675","issn-type":"print"},{"key":"key-10.4103\/0975-7406.282490-24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4103\/0253-7613.40488","article-title":"Adverse drug reactions (ADR) in the inpatients of medicine department of a rural tertiary care teaching hospital and influence of pharmacovigilance in reporting ADR","author":"Gor","year":"2008","journal-title":"Indian J Pharm"},{"key":"key-10.4103\/0975-7406.282490-25","doi-asserted-by":"crossref","first-page":"303","DOI":"10.18203\/2319-2003.ijbcp20180103","article-title":"Retrospective analysis of adverse drug reactions reported at ADR monitoring centre under PvPI in a tertiary care hospital","author":"Sen","year":"2018","journal-title":"Int J Basic Clin Pharmacol"},{"key":"key-10.4103\/0975-7406.282490-26","first-page":"432","article-title":"Adverse drug reactions at adverse drug reaction monitoring center in Raipur: Analysis of spontaneous reports during 1 year","author":"Preeti","year":"2017","journal-title":"Indian J Pharmacol","ISSN":"https:\/\/id.crossref.org\/issn\/0253-7613","issn-type":"print"},{"key":"key-10.4103\/0975-7406.282490-27","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/BF00315403","article-title":"Risk factor for adverse drug reactions\u2014epidemiological approaches","author":"Hoigne","year":"1990","journal-title":"Eur J Clin Pharmacol"},{"key":"key-10.4103\/0975-7406.282490-28","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.18203\/2319-2003.ijbcp20164133","article-title":"Pharmacovigilance study in medicine department in a tertiary care hospital","author":"Mishra","year":"2016","journal-title":"Int J Basic Clin Pharmacol"},{"key":"key-10.4103\/0975-7406.282490-29","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000346737","article-title":"Attitudes and opinion about adverse drug events of women living in a city of south Italy","author":"Salvo","year":"2013","journal-title":"Pharmacology"},{"key":"key-10.4103\/0975-7406.282490-30","doi-asserted-by":"crossref","unstructured":"Tripathi KD. Antitubercular drugs. In: Essentials of medical pharmacology. 7th ed. New Delhi, India: Jaypee Brothers; 2013. p. 765-79.","DOI":"10.5005\/jp\/books\/12021_59"},{"key":"key-10.4103\/0975-7406.282490-31","first-page":"21","article-title":"Adverse events to first line anti-tuberculosis drugs in patients co-infected with HIV and tuberculosis","author":"Michael","year":"2016","journal-title":"Ann Ib Postgrad Med"},{"key":"key-10.4103\/0975-7406.282490-32","first-page":"6","article-title":"Comparison of adverse drug reactions of antitubercular drugs in category 1 tuberculosis patients between daily and intermittent regimen and its impact on outcome","author":"Abhijeet","year":"2017","journal-title":"J Res Med Dent Sci"},{"key":"key-10.4103\/0975-7406.282490-33","first-page":"77","article-title":"Update on the management of antibiotic allergy","author":"Bernard","year":"2010","journal-title":"Allergy Asthma Immunol Res"},{"key":"key-10.4103\/0975-7406.282490-34","doi-asserted-by":"crossref","unstructured":"Gonzalez-Perez A, Aponte Z, Vidaurre CF, Rodriguez LA. Anaphylaxis epidemiology in patients with and patients without asthma: A United Kingdom database review. J Allergy Clin Immunol 2010;125:1098-104.e1.","DOI":"10.1016\/j.jaci.2010.02.009"},{"key":"key-10.4103\/0975-7406.282490-35","doi-asserted-by":"crossref","unstructured":"Torres MJ, Ariza A, Mayorga C, Do\u00f1a I, Blanca-Lopez N, Rondon C, et al. Clavulanic acid can be the component in amoxicillin-clavulanic acid responsible for immediate hypersensitivity reactions. J Allergy Clin Immunol 2010;125:502-5.e2.","DOI":"10.1016\/j.jaci.2009.11.032"},{"key":"key-10.4103\/0975-7406.282490-36","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3389\/fimmu.2017.00614","article-title":"Epidemiology, mechanisms, and diagnosis of drug-induced anaphylaxis","author":"Monta\u00f1ez","year":"2017","journal-title":"Front Immunol"},{"key":"key-10.4103\/0975-7406.282490-37","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.jaip.2017.02.007","article-title":"Patients taking amoxicillin-clavulanic can become simultaneously sensitized to both drugs","author":"Salas","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"key-10.4103\/0975-7406.282490-38","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s40629-018-0064-0","article-title":"NSAID hypersensitivity\u2014recommendations for diagnostic work up and patient management","author":"W\u00f6hrl","year":"2018","journal-title":"Allergo J Int"},{"key":"key-10.4103\/0975-7406.282490-39","doi-asserted-by":"crossref","first-page":"AB196","DOI":"10.1016\/j.jaci.2015.12.772","article-title":"Reported incidence of hypersensitivity reactions to non-steroidal anti-inflammatory drugs in the electronic health record","author":"Blumenthal","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"key-10.4103\/0975-7406.282490-40","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000453265","article-title":"Classification of drug hypersensitivity into allergic, p-i, and pseudo-allergic forms","author":"Pichler","year":"2016","journal-title":"Int Arch Allergy Immunol"},{"key":"key-10.4103\/0975-7406.282490-41","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1056\/NEJMcibr1514013","article-title":"Aspirin-exacerbated respiratory disease\u2014new prime suspects","author":"Laidlaw","year":"2016","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0975-7406.282490-42","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.jaip.2017.08.029","article-title":"Acetyl salicylic acid challenge in children with hypersensitivity reactions to nonsteroidal anti-inflammatory drugs differentiates between cross-intolerant and selective responders","author":"Blanca-L\u00f3pez","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"key-10.4103\/0975-7406.282490-43","first-page":"321","article-title":"A case report on paracetamol induced generalized fixed drug eruptions","author":"Sake","year":"2016","journal-title":"IJPPR Human"},{"key":"key-10.4103\/0975-7406.282490-44","first-page":"S278","article-title":"Paracetamol induced Steven\u2013Johnson syndrome: A rare case report","author":"Rajan","year":"2015","journal-title":"Contemp Clin Dent","ISSN":"https:\/\/id.crossref.org\/issn\/0976-237X","issn-type":"print"},{"key":"key-10.4103\/0975-7406.282490-45","first-page":"524","article-title":"Acetaminophen induced Steven\u2013Johnson syndrome-toxic epidermal necrolysis overlap","author":"Khawaja","year":"2012","journal-title":"J Pak Med Assoc"},{"key":"key-10.4103\/0975-7406.282490-46","doi-asserted-by":"crossref","first-page":"389","DOI":"10.4103\/0378-6323.110749","article-title":"A systematic review of the drug-induced Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in Indian population","author":"Patel","year":"2013","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"https:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/0975-7406.282490-47","first-page":"152","article-title":"Perioperative chlorhexidine allergy: Is it serious?","author":"Claude","year":"2015","journal-title":"J Anaesthesiol Clin Pharmacol","ISSN":"https:\/\/id.crossref.org\/issn\/0970-9185","issn-type":"print"},{"key":"key-10.4103\/0975-7406.282490-48","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jaci.2007.04.029","article-title":"IgE-mediated allergy to chlorhexidine","author":"Garvey","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"key-10.4103\/0975-7406.282490-49","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0030-4220(91)90424-B","article-title":"Chlorhexidine mouthwash-induced fixed drug eruption.Case report and review of the literature","author":"Moghadam","year":"1991","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"key-10.4103\/0975-7406.282490-50","doi-asserted-by":"crossref","first-page":"709","DOI":"10.4168\/aair.2019.11.5.709","article-title":"Severe cutaneous adverse reactions to antiepileptic drugs: A nationwide registry-based study in Korea","author":"Park","year":"2019","journal-title":"Allergy Asthma Immunol Res"},{"key":"key-10.4103\/0975-7406.282490-51","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0161-6420(97)30128-6","article-title":"Corneal endothelial toxicity of topical anesthesia","author":"Judge","year":"1997","journal-title":"Ophthalmology"}],"container-title":["Journal of Pharmacy And Bioallied Sciences"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:48:30Z","timestamp":1786733310000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jpbs.JPBS_226_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"alternative-id":["282490"],"URL":"https:\/\/doi.org\/10.4103\/jpbs.jpbs_226_19","relation":{},"ISSN":["0975-7406"],"issn-type":[{"value":"0975-7406","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}